Akanda Corp. and Tetra Bio-Pharma: Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF, a Potential Multimillion Dollar Prescription Drug
Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer pain medical market
Source: finanznachrichten.de